Zahid Hussain received his M.Sc. degree (2013) in Biochemistry from Punjab University Lahore, and his M.S. degree (2017) in Biochemistry and Molecular Biology from COMSATS University Islamabad. He earned his Ph.D. (2019-23) in the same field at University of Science and Technology of China (USTC). He then joined Suzhou Institute of Nano-Tech and Nano-Bionics (SINANO) as a Research Assistant Professor. His research interests focus on therapeutic nanomaterials, cell surface engineering, and fabrication of cell-instructive scaffolds. He has published up to 35 peer-reviewed academic papers in prestigious journals. Renjun Pei received his Bachelor's and Ph.D. degrees from Department of Chemistry of Wuhan University in 1993 and 1998, respectively. He engaged in research at the Changchun Institute of Applied Chemistry of Chinese Academy of Sciences, Southern Illinois University, Kyoto University, and Columbia University from 1998 to 2011. Since 2011, he has been working as a professor at the Suzhou Institute of Nano-Tech and Nano-Bionics (SINANO), Chinese Academy of Sciences. Together with his research team, his current research interest includes aptamer SELEX and applications, nano-based diagnosis and therapy, organoids, cell surface engineering, and stem cells for tissue regeneration. He has published up to 150 peer-reviewed academic papers in prestigious journals.

• .- Biological Membrane Engineering for Unlocking Therapeutic Potential of Membrane-Based Platforms..- Engineering Cell Membrane-Derived Nanovesicles for Advanced Biomedical Applications..- Engineered Bacterial Membrane Vesicles for Advanced Biomedical Applications..- Hybrid Cell Membrane Engineered Platform for Theranostic Application..- Functional Biomaterials used for Cell Membrane Engineering and their Functional Aspects..- Genetically Mediated Cell Membrane Engineering Strategies and Their Scope in Biomedical Applications..- Biomaterial-Based Cell Membrane Engineering Strategies and Their Scope in Biomedical Applications..- Harnessing Cell Surface Engineering for Tissue Engineering and Regenerative Medicine..- Harnessing Biomaterial-Mediated Single-Cell Nanoencapsulation for Enhanced Cellular Therapies..- Harnessing Engineered Probiotics for Gastrointestinal Diseases Therapy..- Cell Membrane Engineering for Advancing Cancer Immunotherapy..- Cellular Membrane Engineering Platform for Capturing and Neutralizing Circulating Tumor Cells..- Engineered Mammalian Cell and Bacterial Membrane-Based Nanovaccines and Nanoplatforms for Cancer Therapy and Infectious Disease ..- Cell Membrane Engineering for Advancing Precision Drug Delivery for Cancer Therapy..- Cell Membrane Engineering for Advancing Drug Delivery Against Infectious Diseases..- Cell Membrane Engineering for Advanced Drug Delivery Against Neurodegenerative and Inflammatory Diseases.

Zahid Hussain received his M.Sc. degree (2013) in Biochemistry from Punjab University Lahore, and his M.S. degree (2017) in Biochemistry and Molecular Biology from COMSATS University Islamabad. He earned his Ph.D. (2019-23) in the same field at University of Science and Technology of China (USTC). He then joined Suzhou Institute of Nano-Tech and Nano-Bionics (SINANO) as a Research Assistant Professor. His research interests focus on therapeutic nanomaterials, cell surface engineering, and fabrication of cell-instructive scaffolds. He has published up to 35 peer-reviewed academic papers in prestigious journals. Renjun Pei received his Bachelor's and Ph.D. degrees from Department of Chemistry of Wuhan University in 1993 and 1998, respectively. He engaged in research at the Changchun Institute of Applied Chemistry of Chinese Academy of Sciences, Southern Illinois University, Kyoto University, and Columbia University from 1998 to 2011. Since 2011, he has been working as a professor at the Suzhou Institute of Nano-Tech and Nano-Bionics (SINANO), Chinese Academy of Sciences. Together with his research team, his current research interest includes aptamer SELEX and applications, nano-based diagnosis and therapy, organoids, cell surface engineering, and stem cells for tissue regeneration. He has published up to 150 peer-reviewed academic papers in prestigious journals.

• .- Biological Membrane Engineering for Unlocking Therapeutic Potential of Membrane-Based Platforms..- Engineering Cell Membrane-Derived Nanovesicles for Advanced Biomedical Applications..- Engineered Bacterial Membrane Vesicles for Advanced Biomedical Applications..- Hybrid Cell Membrane Engineered Platform for Theranostic Application..- Functional Biomaterials used for Cell Membrane Engineering and their Functional Aspects..- Genetically Mediated Cell Membrane Engineering Strategies and Their Scope in Biomedical Applications..- Biomaterial-Based Cell Membrane Engineering Strategies and Their Scope in Biomedical Applications..- Harnessing Cell Surface Engineering for Tissue Engineering and Regenerative Medicine..- Harnessing Biomaterial-Mediated Single-Cell Nanoencapsulation for Enhanced Cellular Therapies..- Harnessing Engineered Probiotics for Gastrointestinal Diseases Therapy..- Cell Membrane Engineering for Advancing Cancer Immunotherapy..- Cellular Membrane Engineering Platform for Capturing and Neutralizing Circulating Tumor Cells..- Engineered Mammalian Cell and Bacterial Membrane-Based Nanovaccines and Nanoplatforms for Cancer Therapy and Infectious Disease ..- Cell Membrane Engineering for Advancing Precision Drug Delivery for Cancer Therapy..- Cell Membrane Engineering for Advancing Drug Delivery Against Infectious Diseases..- Cell Membrane Engineering for Advanced Drug Delivery Against Neurodegenerative and Inflammatory Diseases.

Zahid Hussain received his M.Sc. degree (2013) in Biochemistry from Punjab University Lahore, and his M.S. degree (2017) in Biochemistry and Molecular Biology from COMSATS University Islamabad. He earned his Ph.D. (2019-23) in the same field at University of Science and Technology of China (USTC). He then joined Suzhou Institute of Nano-Tech and Nano-Bionics (SINANO) as a Research Assistant Professor. His research interests focus on therapeutic nanomaterials, cell surface engineering, and fabrication of cell-instructive scaffolds. He has published up to 35 peer-reviewed academic papers in prestigious journals. Renjun Pei received his Bachelor's and Ph.D. degrees from Department of Chemistry of Wuhan University in 1993 and 1998, respectively. He engaged in research at the Changchun Institute of Applied Chemistry of Chinese Academy of Sciences, Southern Illinois University, Kyoto University, and Columbia University from 1998 to 2011. Since 2011, he has been working as a professor at the Suzhou Institute of Nano-Tech and Nano-Bionics (SINANO), Chinese Academy of Sciences. Together with his research team, his current research interest includes aptamer SELEX and applications, nano-based diagnosis and therapy, organoids, cell surface engineering, and stem cells for tissue regeneration. He has published up to 150 peer-reviewed academic papers in prestigious journals.

• .- Biological Membrane Engineering for Unlocking Therapeutic Potential of Membrane-Based Platforms..- Engineering Cell Membrane-Derived Nanovesicles for Advanced Biomedical Applications..- Engineered Bacterial Membrane Vesicles for Advanced Biomedical Applications..- Hybrid Cell Membrane Engineered Platform for Theranostic Application..- Functional Biomaterials used for Cell Membrane Engineering and their Functional Aspects..- Genetically Mediated Cell Membrane Engineering Strategies and Their Scope in Biomedical Applications..- Biomaterial-Based Cell Membrane Engineering Strategies and Their Scope in Biomedical Applications..- Harnessing Cell Surface Engineering for Tissue Engineering and Regenerative Medicine..- Harnessing Biomaterial-Mediated Single-Cell Nanoencapsulation for Enhanced Cellular Therapies..- Harnessing Engineered Probiotics for Gastrointestinal Diseases Therapy..- Cell Membrane Engineering for Advancing Cancer Immunotherapy..- Cellular Membrane Engineering Platform for Capturing and Neutralizing Circulating Tumor Cells..- Engineered Mammalian Cell and Bacterial Membrane-Based Nanovaccines and Nanoplatforms for Cancer Therapy and Infectious Disease ..- Cell Membrane Engineering for Advancing Precision Drug Delivery for Cancer Therapy..- Cell Membrane Engineering for Advancing Drug Delivery Against Infectious Diseases..- Cell Membrane Engineering for Advanced Drug Delivery Against Neurodegenerative and Inflammatory Diseases.